Na'ILah Insani Alifiyah
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Na'ILah Insani Alifiyah has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
Arie Aryanto
2 shared publicationsHikmah Zikriyani
Department of Biology Faculty of Science and Technology Universitas Terbuka Tangerang Selatan 15437 Banten Indonesia
1 shared publication- Hikmah Zikriyani1 shared publication
- Rizki Rizki1 shared publication
- Wirdatun Nafisah
Universitas Negeri Surabaya
1 shared publication
Latest Publications
- 1 January 2026
- Published by Garval Editorial Ltda. in Journal of Pharmacy & Pharmacognosy Research
- Vol. 14 (1) , 2394
GC-MS profiling and in silico multi-target docking of carvone, p-cymene, and linalool from Cuminum cyminum seeds extract against breast cancer proteins
Context: Breast cancer remains the most prevalent malignancy among women and presents therapeutic challenges due to adverse effects associated with conventional treatments. Cuminum cyminum seeds extract (CCSE), recognized for its antioxidant and antibacterial properties, has been investigated as a potential source of alternative therapeutic agents. Aims: To profile the phytochemical constituents of CCSE using GC-MS and to evaluate the predicted interactions of selected compounds with breast cancer–related proteins through in silico molecular docking analyses. Methods: The ethanolic extract of CCSE was analyzed by GC-MS, yielding the identification of 269 phytoconstituents. From these, three bioactive compounds—carvone, p-cymene, and linalool—were selected for further evaluation. Their potential anticancer activities were predicted using the PASS and CLC-Pred platforms, while drug-likeness properties were assessed through SwissADME. In silico toxicity profiles were also predicted using the ProTox-3.0 webserver. Pathway interactions were analyzed using the STITCH database. Molecular docking studies were then performed with AutoDock Vina in PyRx against Erα, MDM2, HER2, and caspase-3, with doxorubicin used as a reference drug. Results: The selected compounds were predicted to have potential anticancer activity against breast cancer through multiple mechanisms, including regulation of apoptosis. Carvone and p-cymene showed favorable predicted binding affinities for MDM2 and HER2 compared with doxorubicin, suggesting possible tumor-suppressive effects. Linalool was predicted to interact with MDM2, caspase-3, ERα, and HER2, with some affinities comparable to those of doxorubicin, indicating a potential role in modulating apoptosis pathways and receptor-mediated signaling. These findings provide preliminary in silico evidence of the breast cancer–related anticancer potential of CCSE bioactive compounds relative to doxorubicin, and further experimental validation is required. Conclusions: These findings suggest that CCSE-derived compounds may possess potential anticancer activity against breast cancer; however, further in vitro and in vivo validation is necessary.
- 1 January 2026
- Published by Garval Editorial Ltda. in Journal of Pharmacy & Pharmacognosy Research
- Vol. 14 (1) , 2394
GC-MS profiling and in silico multi-target docking of carvone, p-cymene, and linalool from Cuminum cyminum seeds extract against breast cancer proteins
Context: Breast cancer remains the most prevalent malignancy among women and presents therapeutic challenges due to adverse effects associated with conventional treatments. Cuminum cyminum seeds extract (CCSE), recognized for its antioxidant and antibacterial properties, has been investigated as a potential source of alternative therapeutic agents. Aims: To profile the phytochemical constituents of CCSE using GC-MS and to evaluate the predicted interactions of selected compounds with breast cancer–related proteins through in silico molecular docking analyses. Methods: The ethanolic extract of CCSE was analyzed by GC-MS, yielding the identification of 269 phytoconstituents. From these, three bioactive compounds—carvone, p-cymene, and linalool—were selected for further evaluation. Their potential anticancer activities were predicted using the PASS and CLC-Pred platforms, while drug-likeness properties were assessed through SwissADME. In silico toxicity profiles were also predicted using the ProTox-3.0 webserver. Pathway interactions were analyzed using the STITCH database. Molecular docking studies were then performed with AutoDock Vina in PyRx against Erα, MDM2, HER2, and caspase-3, with doxorubicin used as a reference drug. Results: The selected compounds were predicted to have potential anticancer activity against breast cancer through multiple mechanisms, including regulation of apoptosis. Carvone and p-cymene showed favorable predicted binding affinities for MDM2 and HER2 compared with doxorubicin, suggesting possible tumor-suppressive effects. Linalool was predicted to interact with MDM2, caspase-3, ERα, and HER2, with some affinities comparable to those of doxorubicin, indicating a potential role in modulating apoptosis pathways and receptor-mediated signaling. These findings provide preliminary in silico evidence of the breast cancer–related anticancer potential of CCSE bioactive compounds relative to doxorubicin, and further experimental validation is required. Conclusions: These findings suggest that CCSE-derived compounds may possess potential anticancer activity against breast cancer; however, further in vitro and in vivo validation is necessary.
- Open Access
- 1 July 2025
- Published by Universitas Mataram in Jurnal Biologi Tropis
- Vol. 25 (3) , 2488-2499
Phytochemical Constituents, Nutritional Composition, and Pharmacological Potentials of Mangifera foetida: A Comprehensive Review
Mangifera foetida, commonly referred to as bacang, is a tropical fruit tree of the Anacardiaceae family widely used in traditional medicine throughout Southeast Asia for a variety of therapeutic purposes. Recent scientific studies have validated many of these ethnomedicinal uses by uncovering a diverse phytochemical composition alongside notable pharmacological activities. This review synthesizes current knowledge on the nutritional content, bioactive compounds, and pharmacological effects of M. foetida, with particular focus on its antioxidant, antimicrobial, cytotoxic, antidiabetic, and anti-inflammatory properties. Key secondary metabolites, including mangiferin, phenolic compounds, flavonoids, and essential oils, are believed to underpin its therapeutic efficacy. Moreover, the fruit and other plant parts provide considerable nutritional benefits, supplying essential vitamins, minerals, and dietary fiber. Despite these promising findings, further investigations are needed to clarify underlying mechanisms, improve extraction techniques, and evaluate clinical effectiveness. This review seeks to establish a comprehensive reference to support future research and facilitate the development of M. foetida-derived nutraceuticals and pharmaceuticals.
- 1 July 2025
- Published by Universitas Mataram in Jurnal Biologi Tropis
- Vol. 25 (3) , 2488-2499
Open AccessPhytochemical Constituents, Nutritional Composition, and Pharmacological Potentials of Mangifera foetida: A Comprehensive Review
Mangifera foetida, commonly referred to as bacang, is a tropical fruit tree of the Anacardiaceae family widely used in traditional medicine throughout Southeast Asia for a variety of therapeutic purposes. Recent scientific studies have validated many of these ethnomedicinal uses by uncovering a diverse phytochemical composition alongside notable pharmacological activities. This review synthesizes current knowledge on the nutritional content, bioactive compounds, and pharmacological effects of M. foetida, with particular focus on its antioxidant, antimicrobial, cytotoxic, antidiabetic, and anti-inflammatory properties. Key secondary metabolites, including mangiferin, phenolic compounds, flavonoids, and essential oils, are believed to underpin its therapeutic efficacy. Moreover, the fruit and other plant parts provide considerable nutritional benefits, supplying essential vitamins, minerals, and dietary fiber. Despite these promising findings, further investigations are needed to clarify underlying mechanisms, improve extraction techniques, and evaluate clinical effectiveness. This review seeks to establish a comprehensive reference to support future research and facilitate the development of M. foetida-derived nutraceuticals and pharmaceuticals.